White House withdraws Lance Schroyer’s nomination to lead ICE

The White House has withdrawn the nomination of Lance Schroyer to lead U.S. Immigration and Customs Enforcement (ICE). Schroyer, a former Oklahoma state trooper and senior adviser to Homeland Security Secretary Markwayne Mullin, was nominated by President Trump in June. His nomination had stalled in the Senate, as ICE faces ongoing scrutiny over its operations. Republican Senator Rand Paul, who chairs the Senate Homeland Security and Governmental Affairs Committee, had refused to hold a hearing until the Department of Homeland Security provided requested information regarding civilian deaths during ICE enforcement operations. Schroyer had limited experience in immigration and had not previously worked at ICE or led a major law enforcement agency.

The White House has withdrawn its nominee for the director of US Immigration and Customs Enforcement (ICE). Lance Schroyer, a former US Marine and Oklahoma state trooper, had been named by President Trump earlier this year for the position, which requires Senate confirmation. The White House announced the withdrawal in a brief statement on its website, providing no specific reason for the decision. The article notes that Schroyer's nomination had been stalled in the Senate. ICE is the agency responsible for implementing President Trump's immigration enforcement policies.

The White House has withdrawn the nomination of Lance Schroyer, a former Oklahoma state trooper, to lead Immigration and Customs Enforcement (ICE). The decision comes less than three months after his nomination was announced. Critics had raised concerns about Schroyer's lack of formal experience within ICE. He previously served on Homeland Security Secretary Markwayne Mullin's security detail and has since been an adviser to Mullin. The White House did not provide a specific reason for the withdrawal. Schroyer's nomination had stalled in the Senate, as the relevant committee chair had not yet scheduled a hearing. ICE has been without a confirmed director since 2017, with acting directors overseeing the agency.